Ahn CS. Effect of taurine supplementation on plasma homocysteine levels of the middle-aged Korean women. Adv Exp Med Biol, 2009; 643:415-22

Almeida OP et al. B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial. Ann Neurol. 2010 Oct;68(4):503-10

Armitage JM, Bowman L et al. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA. 2010 Jun 23;303(24):2486-94

Atkinson w, Slow S et al. Dietary and supplementary betaine: Effects on betaine and homocysteine concentrations in males. Nutrition, Metabolism & Cardiovascular Diseases (2009) 19:767-773

Baggott JE, Tamura T. Iron-dependent formation of homocysteine from methionine and other thioethers. Eur J Clin Nutr. 2007 Dec;61(12):1359-63. Epub 2007 Feb 14

Bethin KE, Cimato TR et al. Copper binding to mouse liver S-adenosylhomocysteine hydrolase and the effects of copper on its levels. J Biol Chem. 1995 Sep 1;270(35):20703-11.

Bethin KE, Petrovic N et al. Identification of a major hepatic copper binding protein as S-adenosylhomocysteine hydrolase. J Biol Chem. 1995 Sep 1;270(35):20698-702

Boldyrev AA. Molecular mechanisms of homocysteine toxicity. Biochemistry (Moscow); 2009; 74(6):589-598

Breilmann J, Pons-Kühnemann J et al. Effect of Antioxidant Vitamins on the Plasma Homocysteine Level in a Free-Living Elderly Population. Ann Nutr Metab. 2010 Nov 17;57(3-4):177-182. [Epub ahead of print]

Chai H, Dong Y et al. Ginsenoside Rb1 attenuates homocysteine-augmented guidewire injury-induced intimal hyperplasia in mice. J Surg Res. 2009 Dec;157(2):193-8. Epub 2008 Aug 15

Chang P-Y, Lu S-C et al. S-Adenosylhomocysteine: A Better Marker of the Development of Alzheimer's Disease than Homocysteine? Journal of Alzheimer's Disease. 10.3233/JAD-2010-100144

Clarke R, Halsey J, Lewington S et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med. 2010 Oct 11;170(18):1622-31.

Craig SAS. Betaine in human nutrition. Am J Clin Nutr. 2004; 80:539-49

Glomerular Injury and Sclerosis. Am J Nephrol 2008;28:254–264

Green TJ, Skeaff CM et al. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations. Br J Nutr. 2010 Jun;103(11):1629-34. Epub 2010 Jan 21.

Hodis HN, Mack WJ et al. High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial. Stroke. 2009 Mar;40(3):730-6. Epub 2008 Dec 31.

Homocysteine Lowering Trialists' Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr. 2005 Oct;82(4):806-12

Hung C-J, Huang P-C, Lu S-C, et al. Plasma Homocysteine Levels in Taiwanese Vegetarians Are Higher Than Those of Omnivores. J Nutr, 2002;132:152-158

Jakubowski H. Molecular basis of homocysteine toxicity in humans. Cell Mol Life Sci. 2004; 61:470-487

Jakubowski H. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J Physiol Pharmacol. 2008 Dec;59 Suppl 9:155-67. Review.

Jakubowski J. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. Journal of physiology and pharmacology. 2008, 59, suppl 9, 155-167

Kim JH et al. Neuroprotective effects of ginsenoside Rg3 against homocysteine-induced excitotoxicity in rat hippocampus. Brain Res. 2007 Mar 9;1136(1):190-9. Epub 2006 Dec 22.

Kim JH, Cho SY et al. Ginseng saponins diminish adverse vascular effects associated with chronic methionine-induced hyperhomocysteinemia. Biol Pharm Bull. 2006 Dec;29(12):2425-31

Koubaa N, Nakbi A et al. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome. Clin Biochem. 2009 Jun;42(9):771-6. E-pub 2009 Mar 6

McCully KS. The biomedical significance of homocysteine. Journal of Scientific Exploration; 2001; 15(1):5–20

Mouhamed DH, Ezzaher A et al. Effect of cigarette smoking on plasma homocysteine concentrations. Clin Chem Lab Med. 2010 Dec 14. [Epub ahead of print]

Nafar M, Khatami F et al. Role of folic acid in atherosclerosis after kidney transplant: a double-blind, randomized, placebo-controlled clinical trial. Exp Clin Transplant. 2009 Mar;7(1):33-9

Ntaios G, Savopoulos C et al. The effect of folic acid supplementation on carotid intima-media thickness in patients with cardiovascular risk: a randomized, placebo-controlled trial. Int J Cardiol. 2010 Aug 6;143(1):16-9. Epub 2009 Feb 8.

Nys Marleen. Paraoxonasen, beschermers tegen degeneratieziekten en toxiciteit. Arts & Apotheker. 2010; 11(2): 42-47

Obeid R, Herrmann W. Homocysteine, folic acid and vitamin B12 in relation to pre- and postnatal health aspects. Clin Chem Lab Med. 2005;43(10):1052-7

Papandreou D, Rousso I et al. Effects of oral folate supplementation on serum total homocysteine and cholesterol levels in hyperhomocysteinemic children. Nutr Clin Pract. 2010 Aug;25(4):390-3

Perla-Kaján J, Jakubowski H. Paraoxonase 1 protects against protein N-homocysteinylation in humans. FASEB J. 2010 Mar;24(3):931-6. Epub 2009 Oct 30.

Pooya S, Jalali MD et al. The efficacy of omega-3 fatty acid supplementation on plasma homocysteine and malondialdehyde levels of type 2 diabetic patients. Nutr Metab Cardiovasc Dis, 2009 June 18

Ramakrishnan S, Sulochana KN et al. Biochemistry of homocysteine in health and diseases. Indian Journal of Biochemistry & Biophysics. 2006; 43:275-283

Ravaglia G, Forti P et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr. 2005; 82:636-43

Stabler SP, Allen RH et al. Elevated serum S-adenosylhomocysteine in cobalamin-deficient elderly and response to treatment. Am J Clin Nutr. 2006 Dec;84(6):1422-9

Stanger O, Fowler B et al. Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Rev. Neurother. 9(9), 1393–1412 (2009)

Stehouwer CDA, van Gulder Coen. Does homocysteïne cause hypertension? Clin Chem Lab Med 2003; 41(11):1408–1411

Stover PJ. Vitamin B12 and older adults. Curr Opin Clin Nutr Metab Care. 2010; 13:24-27

Van Guelpen B, Hultdin J et al. Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function. J Intern Med. 2009 Aug;266(2):182-95. Epub 2009 Feb 27.

van Guldener Coen. Homocysteine and the kidney. Curr Drugs Metab. 2005; 6:23-26

Verhoef P, de Groot LC. Dietary determinants of plasma homocysteine concentrations. Semin Vasc Med. 2005 May;5(2):110-23.

Wagner C, Koury MJ. S-Adenosylhomocysteine—a better indicator of vascular disease than homocysteine? Am J Clin Nutr 2007;86:1581–5.

Weiss N, Ide N et al. Aged garlic extract improves homocysteine-induced endothelial dysfunction in macro- and microcirculation. J Nutr. 2006 Mar;136(3 Suppl):750S-754S

Yeh YY, Yeh SM. Homocysteine-lowering action is another potential cardiovascular protective factor of aged garlic extract. J Nutr. 2006 Mar;136(3 Suppl):745S-749S.

Yi F, Li P-L. Mechanisms of Homocysteine-Induced

Yilmaz H, Sahin S et al. Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease. Acta Cardiol, 2007; 62(6):579-85

Zhou Ji, Austin RC. Contributions of hyperhomocysteinemia to atherosclerosis: causal relationship and potential mechanisms. Cofactors. 2009; 35(2):120-129

Zoccolella S, dell'Aquila C et al. Elevated homocysteine levels in Parkinson's Disease: is there anything besides L-dopa treatment? Curr Med Chem. 2010;17(3):213-21